← All trials
NCT01246908
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2010
- Primary completion
- May 1, 2012
- Completion date
- May 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 360
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- CeNeRx BioPharma Inc.Lead sponsor
- Radiant ResearchOverall official - principal investigator
- Mclean HospitalOverall official - principal investigator
- NorthCoast Clinical TrialsOverall official - principal investigator
- Stedman Clinical TrialsOverall official - principal investigator
- Richard H. Weisler, M.D. and AssociatesOverall official - principal investigator
- Clinical Neuroscience Solutions, Inc.Overall official - principal investigator
- Northwest Clinical Research CenterOverall official - principal investigator
- Kolin Research GroupOverall official - principal investigator
- Excell ResearchOverall official - principal investigator
- Patient Priority Clinical Sites, LLCOverall official - principal investigator
- Community Clinical Research, Inc.Overall official - principal investigator
- AccelRx ResearchOverall official - principal investigator
- Oregon Center for Clinical Investigations, IncOverall official - principal investigator
- The Segal Institute of Clinical ResearchOverall official - principal investigator
- Northbrooke Research CenterOverall official - principal investigator
- Pacific Clinical ResearchOverall official - principal investigator
- Gulfcoast Clinical Research CenterOverall official - principal investigator
- North Star Medical Research LLCOverall official - principal investigator
- Carman ResearchOverall official - principal investigator
- University of South FloridaOverall official - principal investigator
- Summit Research NetworkOverall official - principal investigator
- Synergy ResearchOverall official - principal investigator
- FutureSearch TrialsOverall official - principal investigator
- Atlanta Institute of Medicine and ResearchOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.